Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Pharmacol Res. 2022 Nov 20;187:106560. doi: 10.1016/j.phrs.2022.106560

Figure 7. Anti-GFP-like immunoreactivity is detectable in the spleens of CB2f/f mice.

Figure 7.

Robust anti-GFP-like immunoreactivity was located in the spleens of CB2f/f mice treated with ddC (A,C) or vehicle (D,F). Sudan black treatment quenched native GFP expression (B, E). Scale bar equal to 1 mm.